Granules Pharmaceuticals Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3701 & 3725 Concorde Parkway, Chantilly, Virginia (VA) 20151, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3011585184 · DUNS 079825711
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-03
- VAIDrug Quality Assurance2023-12-15
- NAIBioresearch Monitoring2023-08-03
- VAIDrug Quality Assurance2022-07-22
- VAIDrug Quality Assurance2017-12-08
Drugs this plant is listed as making
21 distinct drugs across 60 products name this site in their FDA label.
- bupropion hydrochlorideGranules Pharmaceuticals Inc.
- butalbital and acetaminophenGranules Pharmaceuticals Inc.
- Butalbital, Acetaminophen and CaffeineGranules Pharmaceuticals Inc.
- ColchicineGranules Pharmaceuticals Inc.
- Dexmethylphenidate HydrochlorideGranules Pharmaceuticals Inc.
- dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfatein shortageGranules Pharmaceuticals Inc.
- DofetilideExelan Pharmaceuticals, Inc.
- Lisdexamfetamine dimesylatein shortageGranules Pharmaceuticals Inc.
- Methylergonovine MaleateGranules Pharmaceuticals Inc.
- Methylphenidate Hydrochloridein shortageGranules Pharmaceuticals Inc.
- Oxycodone and AcetaminophenGranules Pharmaceuticals Inc.
- PenicillamineGranules Pharmaceuticals Inc.
- Potassium ChlorideGranules Pharmaceuticals Inc.
- Prazosin HydrochlorideGranules Pharmaceuticals Inc.
- ramelteonGranules Pharmaceuticals Inc.
- Trospium ChlorideGranules Pharmaceuticals Inc.
- ValganciclovirGranules Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.